GSE164492 KSR1 knockdown 5 v 0 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE164492_KSR1 knockdown_5_v_0_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE164492_KSR1 knockdown_5_v_0_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE164492_KSR1 knockdown_5_v_0_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE164492_KSR1 knockdown_5_v_0_human_up.

Results found

Linked to

 

Label

Description

 

Gene

mir-100-let-7a-2-mir-125b-1 cluster host gene

Gene

urothelial cancer associated 1

Gene

long intergenic non-protein coding RNA 839

Gene

long intergenic non-protein coding RNA 973

Gene

long intergenic non-protein coding RNA 1234

Gene

uncharacterized LOC105377329

Gene

MIR3667 host gene

Gene

cyclin Y like 2 (pseudogene)

Gene

prothymosin alpha pseudogene 5

Gene

CERS6 antisense RNA 1

  • Gene

    mir-100-let-7a-2-mir-125b-1 cluster host gene


  • Gene

    urothelial cancer associated 1


  • Gene

    long intergenic non-protein coding RNA 839


  • Gene

    long intergenic non-protein coding RNA 973


  • Gene

    long intergenic non-protein coding RNA 1234


  • Gene

    uncharacterized LOC105377329



  • Gene

    cyclin Y like 2 (pseudogene)


  • Gene

    prothymosin alpha pseudogene 5


  • Gene

    CERS6 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.